X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (17221) 17221
Publication (1599) 1599
Book / eBook (439) 439
Book Review (202) 202
Book Chapter (93) 93
Newsletter (83) 83
Newspaper Article (82) 82
Magazine Article (74) 74
Conference Proceeding (20) 20
Web Resource (13) 13
Government Document (9) 9
Dissertation (8) 8
Trade Publication Article (4) 4
Paper (3) 3
Data Set (2) 2
Report (2) 2
Journal / eJournal (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13014) 13014
female (7700) 7700
male (7509) 7509
index medicus (5811) 5811
animals (5291) 5291
middle aged (4485) 4485
adult (4484) 4484
skin diseases - chemically induced (3666) 3666
skin (3535) 3535
dermatology (2886) 2886
aged (2843) 2843
mice (2821) 2821
skin - pathology (2185) 2185
skin neoplasms - chemically induced (1485) 1485
skin - drug effects (1481) 1481
disease models, animal (1398) 1398
oncology (1373) 1373
cancer (1312) 1312
rats (1265) 1265
skin diseases (1110) 1110
adolescent (1106) 1106
pharmacology & pharmacy (1084) 1084
research (1082) 1082
research article (1022) 1022
risk factors (1009) 1009
skin tests (969) 969
time factors (969) 969
drug eruptions - etiology (952) 952
skin diseases - pathology (944) 944
inflammation (940) 940
care and treatment (920) 920
skin and connective tissue diseases (901) 901
medicine (900) 900
immunology (889) 889
therapy (888) 888
dermatology & venereal diseases (887) 887
health aspects (878) 878
toxicology (854) 854
skin neoplasms - pathology (814) 814
child (793) 793
antineoplastic agents - adverse effects (776) 776
treatment outcome (776) 776
article (766) 766
occupational diseases - chemically induced (742) 742
dose-response relationship, drug (737) 737
analysis (725) 725
expression (713) 713
skin neoplasms - drug therapy (688) 688
skin - metabolism (676) 676
cell biology (670) 670
allergy (666) 666
multidisciplinary sciences (665) 665
aged, 80 and over (642) 642
skin diseases, vesiculobullous - chemically induced (626) 626
skin cancer (615) 615
diagnosis, differential (581) 581
rodents (580) 580
melanoma (572) 572
digestive, oral, and skin physiology (569) 569
disease (563) 563
proteins (563) 563
skin diseases - drug therapy (552) 552
gene expression (550) 550
science (543) 543
administration, topical (536) 536
mice, inbred c57bl (533) 533
biopsy (532) 532
medicine, general & internal (528) 528
toxicity (528) 528
tumors (521) 521
diagnosis (517) 517
dermatitis (506) 506
integumentary system (495) 495
drug therapy (494) 494
diseases (487) 487
physiological aspects (482) 482
psoriasis (479) 479
complications and side effects (476) 476
apoptosis (474) 474
cells (473) 473
young adult (469) 469
follow-up studies (467) 467
biochemistry & molecular biology (459) 459
risk (457) 457
retrospective studies (448) 448
chemotherapy (443) 443
child, preschool (439) 439
melanoma - drug therapy (437) 437
immunohistochemistry (433) 433
necrosis (431) 431
oxidative stress (426) 426
surgery (423) 423
public, environmental & occupational health (422) 422
cells, cultured (418) 418
studies (410) 410
abridged index medicus (404) 404
biochemistry (403) 403
carcinogenesis (399) 399
pathology (396) 396
biology (389) 389
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (368) 368
Online Resources - Online (19) 19
Collection Dvlpm't (Acquisitions) - Closed Orders (17) 17
Collection Dvlpm't (Acquisitions) - Vendor file (15) 15
UTL at Downsview - May be requested (12) 12
Scarborough Hospital - General (8) 8
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (6) 6
Royal Ontario Museum - Stacks (4) 4
Lakeridge Health Sciences - Oshawa (3) 3
St. Michael's Hospital - Stacks (3) 3
Toronto East General Hospital - Stacks (3) 3
Providence Healthcare - Reference (2) 2
Providence Healthcare - Stacks (2) 2
Scarborough Hospital - Birchmount (2) 2
UofT at Mississauga - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Women's College Hospital - Stacks (2) 2
Credit Valley Hospital - Stacks (1) 1
Earth Sciences (Noranda) - Reference (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Engineering & Comp. Sci. - Reference (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Missing (1) 1
Gerstein Science - Searching (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Pharmacy (1) 1
Reference (1) 1
Robarts - Stacks (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Toronto East General Hospital - Online (1) 1
UofT at Scarborough - Withdrawn (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16299) 16299
German (533) 533
French (474) 474
Russian (165) 165
Spanish (138) 138
Japanese (102) 102
Italian (76) 76
Polish (56) 56
Portuguese (31) 31
Dutch (30) 30
Danish (29) 29
Chinese (28) 28
Norwegian (18) 18
Czech (15) 15
Hebrew (8) 8
Swedish (8) 8
Finnish (6) 6
Hungarian (5) 5
Slovak (5) 5
Arabic (4) 4
Bulgarian (4) 4
Romanian (4) 4
Korean (3) 3
Serbian (3) 3
Croatian (2) 2
Ukrainian (2) 2
Slovenian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 07/2012, Volume 30, Issue 21, pp. 2691 - 2697
Monoclonal antibodies directed against the immune checkpoint protein cytotoxic T-lymphocyte antigen-4 (CTLA-4; CD152)-ipilimumab and tremelimumab-have been... 
REGRESSION | METASTATIC MELANOMA | LYMPHOCYTE-ASSOCIATED ANTIGEN-4 | EFFICACY | ONCOLOGY | PHASE-II | MONOCLONAL-ANTIBODY | CTLA-4 | PATIENT | CANCER-IMMUNOTHERAPY | BLOCKADE | Stevens-Johnson Syndrome - immunology | Peripheral Nervous System Diseases - chemically induced | Skin Neoplasms - drug therapy | Humans | Ipilimumab | Antibodies, Monoclonal - adverse effects | Scleritis - chemically induced | Antineoplastic Agents - administration & dosage | Liver - immunology | Liver - drug effects | Antineoplastic Agents - adverse effects | Diarrhea - immunology | Pancreatitis - immunology | Scleritis - immunology | Mucous Membrane - drug effects | Colitis - immunology | Peripheral Nervous System Diseases - immunology | Antibodies, Monoclonal - immunology | Drug Eruptions - immunology | Skin - immunology | Melanoma - metabolism | Skin Neoplasms - pathology | Skin Neoplasms - immunology | Antineoplastic Agents - immunology | CTLA-4 Antigen - drug effects | Lymphatic Diseases - immunology | Antibodies, Monoclonal - pharmacokinetics | CTLA-4 Antigen - immunology | Pancreatitis - chemically induced | Melanoma - secondary | Chemical and Drug Induced Liver Injury - immunology | Pituitary Gland - immunology | Skin Neoplasms - metabolism | Lymphatic Diseases - chemically induced | Mucous Membrane - immunology | Antibodies, Monoclonal - administration & dosage | Melanoma - immunology | Uveitis - immunology | Melanoma - drug therapy | Uveitis - chemically induced | Pituitary Gland - drug effects | Skin - drug effects | Index Medicus
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 60, pp. 210 - 225
Journal Article
Models in dermatology, ISSN 0259-1340, 1985
Journal
The New England Journal of Medicine, ISSN 0028-4793, 07/2014, Volume 371, Issue 3, pp. 203 - 212
Adults with vascular disease were treated with a statin to lower LDL cholesterol and were assigned to receive either extended-release niacin plus laropiprant... 
NICOTINIC-ACID | LDL CHOLESTEROL | MEDICINE, GENERAL & INTERNAL | METABOLIC SYNDROME | MYOCARDIAL-INFARCTION | RANDOMIZED-TRIALS | EFFICACY | SAFETY | PLACEBO-CONTROLLED TRIAL | NIACIN/LAROPIPRANT | DYSLIPIDEMIA | Follow-Up Studies | Humans | Middle Aged | Male | Hypercholesterolemia - drug therapy | Indoles - administration & dosage | Infection - chemically induced | Niacin - administration & dosage | Treatment Failure | Musculoskeletal Diseases - chemically induced | Niacin - adverse effects | Cholesterol, LDL - blood | Female | Hypolipidemic Agents - adverse effects | Atherosclerosis - drug therapy | Double-Blind Method | Risk Factors | Indoles - adverse effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Hypolipidemic Agents - administration & dosage | Diabetes Mellitus - chemically induced | Aged | Hemorrhage - chemically induced | Delayed-Action Preparations | Drug Combinations | Dose-response relationship (Biochemistry) | Laropiprant | Blood circulation disorders | Care and treatment | Dosage and administration | Niacin | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Heart attacks | Risk groups | Diabetes mellitus | Cardiovascular disease | Low density lipoprotein | Cholesterol | Musculoskeletal system | Vascular diseases | Arteriosclerosis | Vitamin B | Skin | Lipoproteins (high density) | Drug dosages | Statins
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 03/2010, Volume 34, Issue 3, pp. 405 - 417
We describe a series of Epstein Barr virus (EBV)-positive circumscribed, ulcerative lesions associated with various types of immunosuppression (IS). The study... 
Immunosuppression | Lymphoprolifeative | Epstein Barr virus | Mucocutaneous | SURGERY | CELL LYMPHOPROLIFERATIVE DISORDERS | OPTIMAL PRIMER SELECTION | NON-HODGKINS-LYMPHOMAS | immunosuppression | lymphoproliferative | PERIPHERAL-BLOOD | PATHOLOGY | CD8(+) T-CELLS | LYMPHOCYTE SUBPOPULATIONS | mucocutaneous | CYTOMEGALOVIRUS SEROPOSITIVITY | CHAIN-REACTION ANALYSIS | ELDERLY-PATIENTS | EPSTEIN-BARR-VIRUS | Immunohistochemistry | Recurrence | Humans | Middle Aged | Lymphoproliferative Disorders - chemically induced | Male | Skin Ulcer - immunology | Gastrointestinal Diseases - virology | T-Lymphocytes - virology | Epstein-Barr Virus Infections - etiology | Epstein-Barr Virus Infections - therapy | T-Lymphocytes - drug effects | Aged, 80 and over | B-Lymphocytes - virology | Gastrointestinal Diseases - pathology | Skin Diseases, Infectious - virology | Skin Diseases, Infectious - pathology | Mouth Mucosa - immunology | Immune Tolerance | Gastrointestinal Diseases - therapy | Lymphoproliferative Disorders - pathology | Epstein-Barr Virus Infections - pathology | B-Lymphocytes - immunology | Mouth Mucosa - virology | Remission, Spontaneous | T-Lymphocytes - immunology | Oral Ulcer - pathology | Skin Diseases, Infectious - immunology | Age Factors | Oral Ulcer - immunology | Lymphoproliferative Disorders - immunology | Lymphoproliferative Disorders - therapy | Oral Ulcer - chemically induced | Mouth Mucosa - drug effects | In Situ Hybridization | Epstein-Barr Virus Infections - chemically induced | Polymerase Chain Reaction | Adult | Female | Skin Ulcer - virology | Skin Diseases, Infectious - therapy | Gastrointestinal Diseases - immunology | Skin Ulcer - therapy | Epstein-Barr Virus Infections - immunology | Gene Rearrangement, T-Lymphocyte | Lymphoproliferative Disorders - virology | Skin Diseases, Infectious - chemically induced | Treatment Outcome | Skin Ulcer - chemically induced | Genes, Immunoglobulin | B-Lymphocytes - drug effects | Oral Ulcer - therapy | Skin Ulcer - pathology | Immunosuppressive Agents - adverse effects | Aged | Oral Ulcer - virology | Gastrointestinal Diseases - chemically induced | Muco-cutaneous | Lymphoproliferative
Journal Article